Trowbridge had served as interim CFO since Oct. 22, 2019, and was officially placed in the role on Feb. 5, 2020. He also served as a senior VP and as general counsel. Trowbridge is set to retain his duties as general counsel until a replacement is named, according to a news release.
“I am excited to assume the CFO role on a permanent basis,” Trowbridge said in the news release. “I look forward to continuing to work closely with [president & CEO Jim Clemmer] and the rest of the team as we enter larger, faster-growing markets and bring innovative new products to healthcare professionals and patients around the globe.”
Trowbridge joined AngioDynamics as corporate counsel in 2008 and earned a promotion to VP and general counsel in 2010, followed by a promotion to senior VP, general counsel in 2013.
Before AngioDynamics, Trowbridge held the role of corporate counsel at Philips Healthcare and Intermagnetics General Corporation.